Evidence map›Paper›PMID 39971915›Full record

ArticleCell death & disease2025

Unravelling genotype-phenotype correlations in Stargardt disease using patient-derived retinal organoids.

Avril Watson, Rachel Queen, Luis Ferrández-Peral, Birthe Dorgau, Joseph Collin, Andrew Nelson, Rafiqul Hussain, Jonathan Coxhead, Michael McCorkindale, Robert Atkinson and 6 more

Abstract read
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Avril WatsonBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Rachel QueenBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Luis Ferrández-PeralInstitute for Integrative Systems Biology, University of Valencia, Valencia, Spain.ORCID http://orcid.org/0000-0003-0338-0603
Birthe DorgauBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.ORCID http://orcid.org/0000-0003-4031-4402
Joseph CollinBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Andrew NelsonNU-OMICs, Northumbria University, Newcastle Upon Tyne, UK.
Rafiqul HussainBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Jonathan CoxheadBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Michael McCorkindaleBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Robert AtkinsonBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Darin ZertiDepartment of Biotechnological and Applied Clinical Sciences, Università degli Studi dell'Aquila, L'Aquila, Italy.
Valeria ChichagovaNewcells Biotech Ltd., Newcastle upon Tyne, UK.
Ana ConesaInstitute for Integrative Systems Biology, University of Valencia, Valencia, Spain.
Lyle ArmstrongBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
Frans P M CremersDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
Majlinda LakoBiosciences Institute, Newcastle University, Newcastle upon Tyne, UK. majlinda.lako@ncl.ac.uk.ORCID http://orcid.org/0000-0003-1327-8573

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stargardt disease is an inherited retinopathy affecting approximately 1:8000 individuals. It is characterised by biallelic variants in ABCA4 which encodes a vital protein for the recycling of retinaldehydes in the retina. Despite its prevalence and impact, there are currently no treatments available for this condition. Furthermore, 35% of STGD1 cases remain genetically unsolved. To investigate the cellular and molecular characteristics associated with STGD1, we generated iPSCs from two monoallelic unresolved (PT1 & PT2), late-onset STGD1 cases with the heterozygous complex allele - c.[5461-10 T > C;5603 A > T]. Both patient iPSCs and those from a biallelic affected control (AC) carrying -c.4892 T > C and c.4539+2001G > A, were differentiated to retinal organoids, which developed all key retinal neurons and photoreceptors with outer segments positive for ABCA4 expression. We observed patient-specific disruption to lamination with OPN1MW/LW

Indexed as

Genetic Association StudiesOrganoidsRetinaStargardt DiseaseATP-Binding Cassette TransportersCell DifferentiationFemaleHumansInduced Pluripotent Stem CellsMalePhenotypeABCA4 protein, humanATP-Binding Cassette Transporters

Identifiers

PMID39971915
PMCPMC11840025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.